Fecal Transplant to Prevent Repeat Urinary Tract Infections
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a fecal microbiota transplant (a procedure that transfers healthy bacteria from a donor's stool into your gut) can help prevent repeat urinary tract infections in women who have frequent infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have had at least 2 urinary tract infections in the last 6 months, or at least 3 in the last year, with the most recent one in the past 3 months.
- You do not have a gastrointestinal disease (like Crohn's disease, ulcerative colitis, or irritable bowel syndrome).
- You are not pregnant.
- You do not have a weakened immune system (for example, from a medical condition or certain medications).
- You do not use a permanent urinary catheter or need to catheterize yourself.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at fecal microbiota transplantation (FMT), which is a stool bacteria transplant, to help adults whose symptoms persist or return, often from C. difficile infection. If you’re already planning or receiving FMT for certain conditions, this trial may add information on how it helps and who benefits.
This trial tests if capsules containing fecal microbiota can prevent further Clostridioides difficile infections in people who have had at least two recurrences. If you've had multiple C. diff infections and your symptoms go away with antibiotics, this treatment might help keep them from coming back.
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
This trial studies using a fecal microbiota transplant (FMT)—healthy gut bacteria moved from a screened donor—to help treat recurring or hard-to-control C. difficile infection. It may help restore a healthier gut environment when standard treatments keep failing or the infection returns.
This trial studies whether fecal microbiota transplantation (a procedure that transfers healthy stool bacteria) can change a person’s gut bacteria after repeated C. difficile infection. It may help reduce recurring infections by restoring a healthier balance of gut microbes.
This study looks at how fecal microbiota transplantation (a transplant of healthy gut bacteria) works for people who get C. difficile infection repeatedly. It also focuses on collecting follow-up information to better understand which patients benefit and how.
Hear when a new Recurrent Urinary Tract Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.